Results 221 to 230 of about 492,732 (252)
Some of the next articles are maybe not open access.

Oral Hydromorphone Extended-Release

The Consultant Pharmacist, 2010
To review the chemistry, pharmacodynamics, pharmacokinetics, efficacy, tolerability, dosing, and role of the Osmotic-controlled Release Oral delivery System (OROS) hydromorphone extended-release (ER) tablets.A MEDLINE/PUBMED search (1986-August 2010) was conducted to identify studies in the English language, with additional references being obtained ...
openaire   +2 more sources

Tapentadol Extended Release

Drugs, 2012
The extended release (ER; as ascribed in the US) or prolonged release (PR; as ascribed in Europe) formulation (hereafter referred to as ER) of the oral analgesic tapentadol is believed to exert its analgesic effects via μ-opioid receptor agonistic and norepinephrine reuptake inhibitory activity.
openaire   +2 more sources

Extended Release

American Journal of Gastroenterology, 2005
Christopher D. Wells   +4 more
openaire   +1 more source

Extended-Released Morphine Products

American Journal of Nursing, 1996
M, McCaffery, C, Lochmann
openaire   +2 more sources

Release mechanisms and applications of drug delivery systems for extended-release

Expert Opinion on Drug Delivery, 2020
Renhe Liu, Yao Fu, W John Kao
exaly  

Guanfacine Extended Release

Canadian Journal of Health Technologies
The Formulary Management Expert Committee (FMEC) recommends that guanfacine extended release (XR) be reimbursed for the adjunct therapy to psychostimulants for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children and adolescents, aged 6 years to 17 years, whose disease has responded suboptimally to psychostimulants, provided ...
openaire   +1 more source

Effect of extended-release niacin on plasma lipoprotein(a) levels: A systematic review and meta-analysis of randomized placebo-controlled trials

Metabolism: Clinical and Experimental, 2016
Zeljko Reiner   +2 more
exaly  

Home - About - Disclaimer - Privacy